Latest Debt Facility News

Recce Pharmaceuticals reported a 21% increase in net loss to $21.4 million for FY2025, driven by intensified R&D spending. The company secured key regulatory approvals for Phase 3 trials of its lead anti-infective gel and bolstered its financial position with significant capital raises and grants.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

Mayfield Childcare Limited reported a 14.9% revenue increase to $43.9 million for the half-year ended June 2025, but underlying earnings fell short due to occupancy struggles and underperforming acquisitions. The company faces a significant goodwill impairment and is focused on operational recovery.

Range International Limited reported a significantly reduced half-year loss alongside a 63% revenue increase, driven by strong pallet sales and resolution of Indonesian tax disputes. The company is now positioning for growth with factory relocations and new market entries.

Delorean Corporation reported a strategic shift in FY25, transitioning from third-party bioenergy construction to owning and operating renewable gas infrastructure, resulting in a $4.1 million loss but positioning the company for future multi-revenue growth.

Synertec Corporation has secured an additional A$4 million in debt funding from Altor Capital, expanding its total facility to A$19 million and reinforcing its financial position to support the expansion of its renewable microgrid technology.

Cyprium Metals Limited has launched an A$80 million capital raise to fast-track the restart of its Nifty Copper Complex, aiming to unlock significant value from its brownfield assets. The funds will support refurbishment, feasibility studies, and strengthen the company’s balance sheet.

Atomos Ltd reported a 9% revenue decline to $32.7 million for FY25 but improved its loss after tax by 35%, driven by cost restructuring and tighter expense control amid challenging market conditions.

Elanor Investors Group reported a substantial $157.8 million net loss for FY24 amid asset devaluations and debt covenant breaches, prompting a strategic recapitalisation and leadership transition.

AssetOwl Limited reports a modest net profit for FY2025, driven by a significant gain on debt extinguishment, while grappling with ASX suspension and ongoing going concern challenges.

Mad Paws Holdings has completed the divestment of its Pet Chemist business and announced the resignation of Executive Director Howard Humphreys, advancing its proposed acquisition by Rover Group.

Elixinol Wellness Limited reported a 12.8% increase in revenue to $7.64 million for the half-year ended June 2025, yet its net loss widened by 12.2% to $3.09 million, reflecting higher marketing and restructuring expenses following recent acquisitions.